Search for: "Teva Pharmaceuticals"
Results 1221 - 1240
of 1,430
Sorted by Relevance
|
Sort by Date
10 Feb 2011, 5:35 pm
As a first applicant, Teva qualified for 180-day exclusivity. [read post]
23 Feb 2008, 4:24 am
In an earlier case, Teva Pharmaceuticals USA v. [read post]
18 Jul 2008, 8:34 am
: (Patent Circle), Tanzania to conduct study on impact of counterfeit medicines: (Afro-IP), US: New rules on generic biological medicines under US Congressional debate: (Intellectual Property Watch), Pharma & Biotech - Products Acular (Ketorolac) – US: CAFC rules against Apotex reverse doctrine of equivalents: Roche Palo Alto & Allergan, Inc v Apotex: (Patent Circle), Carbatrol (Carbamazapine) – US: Federal judge allows Corepharma to seek DJ that its application… [read post]
13 Dec 2018, 4:05 pm
MSD was granted an SPC for the product ezetimibe, if desired in the form of a pharmaceutically acceptable salt thereof, on the basis of its patent EP 0 720 599 (the Basic Patent). [read post]
24 Jul 2009, 1:49 am
Teva Pharmaceuticals USA Inc.INTELLECTUAL PROPERTY - Patents"In granting Eisai's motion to strike in this patent infringement case, the judge erred where she misapplied Rule 9(b) and it cannot be held as a matter of law that Teva's allegations have no possible relation to its defense. [read post]
1 Apr 2008, 10:20 am
The first ANDA applicant to file paragraph IV certifications to the '712 and '941 patents was Ivax Pharmaceuticals (since acquired by Teva). [read post]
30 Dec 2016, 2:58 pm
Permission to appeal in patent cases - farewell to the Pozzoli approachGuest Kat Eibhlin Vardy recaps the case Teva UK Ltd v Boehringer Ingelheim Pharma GmbH & Co KG, [2016] EWCA Civ 1296. [read post]
22 Jul 2022, 6:55 am
Reuters reported that Teva Pharmaceutical Industries (TEVA.TA) and AbbVie's Allergan unit reached a $58 million settlement with the city of San Francisco. [read post]
2 Apr 2019, 3:46 pm
Pulse, Teva v. [read post]
18 Jan 2015, 3:52 am
This Katpost discusses Teva v Leo and whether ‘reasonable expectation of success’ should have been used as part of inventive step analysis. [read post]
9 May 2017, 4:42 am
Arnold J. reiterated his view (expressed previously in Teva UK Ltd v Gilead Sciences Inc [2017] EWHC 13 (Pat)) that the test in Lilly remains unclear. [read post]
27 Apr 2015, 10:56 am
The only reference to starting dose was as follows:The TTS of the invention allows, e.g., the manufacture of once a day pharmaceutical forms for patients who have to take more than one dose of an active agent per day, e.g., at specific times, so that their treatment is simplified. [read post]
7 Sep 2015, 1:02 pm
Pointing to a number of shortcomings in patents in agriculture and pharmaceuticals, The Economist concludes that patents don’t. [read post]
3 Mar 2015, 1:55 am
Indeed, the cross-undertaking was ultimately granted in favour of the Actavis group, the Teva group and Dr Reddy’s Laboratories, in addition to the public bodies. [read post]
18 May 2015, 11:01 am
******************PREVIOUSLY, ON NEVER TOO LATENever too late 45 [week ending on Sunday 10 May] – INTA 2015 and the Kat | IP and Competition Law | Sky v Skype | CJEU v Spain | Digital Single Market Strategy | IPCom v HTC | European Qualifying Examination appealed | UPC fees | CJEU and 3-D marks | EPO Oral Proceedings.Never too late 44 [week ending on Sunday 3 May] – Forgotten principles and histories, and the role of complexity in patent law… [read post]
2 Sep 2010, 10:51 am
Teva Pharmaceuticals USA, Inc., 566 F.3d 989 (Fed. [read post]
11 Dec 2013, 7:55 pm
Teva Pharm. [read post]
31 Oct 2018, 5:09 pm
As I noted here, Allergan, Teva Pharmaceuticals, and Endo International (whose Par Pharmaceuticals unit is caught up in the investigation) – all three companies that have been identified by name in connection with the alleged generic drug price-fixing conspiracy – previously were hit with securities class action lawsuit related to the price-fixing investigation. [read post]
25 Jun 2018, 11:38 am
Teva Pharmaceuticals [docket; cert. petition, PDF] is whether, under the Leahy-Smith America Invents Act, an inventor’s sale of an invention to a third party that is obligated to keep the invention confidential qualifies as “prior art” for purposes of determining the patentability of the invention. [read post]
30 Jun 2014, 3:13 pm
The case of Teva Pharmaceuticals v. [read post]
